Ercefuryl is one of many brand names like Ambatrol, Antinal, Bacifurane, Diafuryl (FR), Nifrozid, Erfuzide (TH), Endiex,Endiaron, Ercefurin, Nifuroksazyd (CZ, SK, PL), Pérabacticel (FR), Pentofuryl (DE) Enteral (Afrique Norte) and Septidiaryl containing Nifuroxazide.
Nifuroxazide (INN) is an oral nitrofuran antibiotic, patented since 1966 and used to treat colitis and diarrhea in humans and non-humans. It is sold in capsule form and also as a suspension. The pharmaceutical group SmithKline Beecham claims that nifuroxazide is highly effective and the consumers' group Healthy Skepticism says that SmithKline Beecham's claims have no scientific support.
Ercefuryl, also known as nifuroxazide, is an antidiarrheal agent that works primarily by inhibiting the growth of bacteria in the gastrointestinal tract. Its mode of action involves interference with bacterial enzyme systems, leading to the disruption of bacterial metabolism and cell wall synthesis. This helps to reduce the frequency and severity of diarrhea caused by infections. Additionally, Ercefuryl has a local action in the gut, which helps to restore the intestinal flora balance.
Ercefuryl, also known as nifuroxazide, is an anti-diarrheal medication that primarily acts by inhibiting the growth of bacteria in the intestines. It works by disrupting the bacterial cell wall and interfering with their metabolism, which helps to reduce diarrhea caused by infectious agents. Additionally, it has anti-inflammatory properties that can help soothe the intestinal lining. However, it does not affect the normal intestinal flora or treat viral infections.